Funded Tech Companies
TuHURA Biosciences
Based in Tampa, TuHURA Biosciences has funding from private investors.
Company Overview
Company Name
TuHURA Biosciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
10500 University Center Drive 110
Tampa, FL 33612
USA
Tampa, FL 33612
USA
Phone
Website
Email Address
Company Background Information
Overview
TuHURA Biosciences, Inc. (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. TuHURA's lead innate immune response agonist candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. TuHURA is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda® (pembrolizumab) in first line treatment for advanced or metastatic Merkel Cell Carcinoma.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/3/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Bianco
Chief Financial Officer
Dan Dearborn
Executive Vice President
Bertrand Le Bourdonnec
VP - Operations
Peter O'Neill
VP - Regulatory Affairs
Adeana Dorsey
VP - Regulatory Affairs
Michael Krsulich
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs